Bliss E. Thiel

Learn More
The present study was designed to determine if an oral live Bordetella bronchiseptica vaccine protects dogs from developing signs of respiratory disease after challenge with virulent Bordetella bronchiseptica. The study was also designed to compare the level of protection induced by the oral vaccine with the protection provided by an intranasal live vaccine(More)
Since first emerging in the North American canine population in 2004, canine influenza virus (CIV) subtype H3N8 has shown horizontal transmission among dogs, with a high level of adaptation to this species. The severity of disease is variable, and coinfection by other respiratory pathogens is an important factor in the degree of morbidity and mortality. The(More)
  • 1